Cita APA

Martín, M., Makhson, A., Gligorov, J., Lichinitser, M., Lluch, A., Semiglazov, V., . . . Tjulandin, S. (2012). Phase II Study of Bevacizumab in Combination with Trastuzumab and Capecitabine as First-Line Treatment for HER-2-positive Locally Recurrent or Metastatic Breast Cancer. AlphaMed Press.

Chicago Style Citation

Martín, Miguel, Anatoly Makhson, Joseph Gligorov, Mikhail Lichinitser, Ana Lluch, Vladimir Semiglazov, Nana Scotto, Lada Mitchell, i Sergei Tjulandin. Phase II Study of Bevacizumab in Combination With Trastuzumab and Capecitabine As First-Line Treatment for HER-2-positive Locally Recurrent or Metastatic Breast Cancer. AlphaMed Press, 2012.

Cita MLA

Martín, Miguel, et al. Phase II Study of Bevacizumab in Combination With Trastuzumab and Capecitabine As First-Line Treatment for HER-2-positive Locally Recurrent or Metastatic Breast Cancer. AlphaMed Press, 2012.